Today, FDA issued an EUA for convalescent plasma as part of ongoing efforts to fight COVID-19. Based on scientific evidence available, FDA concluded, this product may be effective in treating COVID-19.
Read more: FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID–19 Treatment, Another Achievement in Administration’s Fight Against Pandemic